Suppr超能文献

相似文献

1
A spatiotemporal hypothesis for the regulation, role, and targeting of AMPK in prostate cancer.
Nat Rev Urol. 2017 Mar;14(3):164-180. doi: 10.1038/nrurol.2016.272. Epub 2017 Feb 1.
2
Targeting the 5'-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer.
Expert Opin Ther Targets. 2015 May;19(5):617-32. doi: 10.1517/14728222.2015.1005603. Epub 2015 Jan 20.
4
A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis.
EMBO Mol Med. 2014 Apr;6(4):519-38. doi: 10.1002/emmm.201302734. Epub 2014 Feb 4.
5
AMPed up to treat prostate cancer: novel AMPK activators emerge for cancer therapy.
EMBO Mol Med. 2014 Apr;6(4):439-41. doi: 10.1002/emmm.201303737. Epub 2014 Feb 20.
6
Metabolic alterations and targeted therapies in prostate cancer.
J Pathol. 2011 Jan;223(2):283-94. doi: 10.1002/path.2809. Epub 2010 Nov 16.
7
AMPK's double-faced role in advanced stages of prostate cancer.
Clin Transl Oncol. 2022 Nov;24(11):2064-2073. doi: 10.1007/s12094-022-02874-z. Epub 2022 Jul 4.
8
Promise and challenges for direct small molecule AMPK activators.
Biochem Pharmacol. 2018 Jul;153:147-158. doi: 10.1016/j.bcp.2018.01.049. Epub 2018 Feb 3.

引用本文的文献

1
Cholesterol metabolism regulated by CAMKK2-CREB signaling promotes castration-resistant prostate cancer.
Cell Rep. 2025 Jun 24;44(6):115792. doi: 10.1016/j.celrep.2025.115792. Epub 2025 Jun 7.
2
Energy Metabolism Profiling of Human Colorectal Tumours.
J Cell Mol Med. 2025 Mar;29(5):e70462. doi: 10.1111/jcmm.70462.
3
Mitochondrial uncouplers inhibit oncogenic E2F1 activity and prostate cancer growth.
Cell Rep Med. 2025 Jan 21;6(1):101890. doi: 10.1016/j.xcrm.2024.101890. Epub 2025 Jan 9.
4
Metformin-based nanomedicines for reprogramming tumor immune microenvironment.
Theranostics. 2025 Jan 1;15(3):993-1016. doi: 10.7150/thno.104872. eCollection 2025.
5
Fine-tuning AMPK in physiology and disease using point-mutant mouse models.
Dis Model Mech. 2024 Aug 1;17(8). doi: 10.1242/dmm.050798. Epub 2024 Aug 13.
7
Unlocking ferroptosis in prostate cancer - the road to novel therapies and imaging markers.
Nat Rev Urol. 2024 Oct;21(10):615-637. doi: 10.1038/s41585-024-00869-9. Epub 2024 Apr 16.
8
A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer.
Mol Cancer Ther. 2024 Jul 2;23(7):973-994. doi: 10.1158/1535-7163.MCT-23-0540.

本文引用的文献

1
Are Metformin Doses Used in Murine Cancer Models Clinically Relevant?
Cell Metab. 2016 Apr 12;23(4):569-70. doi: 10.1016/j.cmet.2016.03.010.
2
Metformin Pharmacokinetics in Mouse Tumors: Implications for Human Therapy.
Cell Metab. 2016 Apr 12;23(4):567-8. doi: 10.1016/j.cmet.2016.03.006.
4
CAMKK2, Regulated by Promoter Methylation, is a Prognostic Marker in Diffuse Gliomas.
CNS Neurosci Ther. 2016 Jun;22(6):518-24. doi: 10.1111/cns.12531. Epub 2016 Mar 25.
5
Repurposing metformin for cancer treatment: current clinical studies.
Oncotarget. 2016 Jun 28;7(26):40767-40780. doi: 10.18632/oncotarget.8194.
6
Systematic meta-analyses of gene-specific genetic association studies in prostate cancer.
Oncotarget. 2016 Apr 19;7(16):22271-84. doi: 10.18632/oncotarget.7926.
7
Atg7 cooperates with Pten loss to drive prostate cancer tumor growth.
Genes Dev. 2016 Feb 15;30(4):399-407. doi: 10.1101/gad.274134.115.
8
Metabolism. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress.
Science. 2016 Jan 15;351(6270):275-281. doi: 10.1126/science.aab4138.
9
The PGC-1α/ERRα Axis Represses One-Carbon Metabolism and Promotes Sensitivity to Anti-folate Therapy in Breast Cancer.
Cell Rep. 2016 Feb 2;14(4):920-931. doi: 10.1016/j.celrep.2015.12.086. Epub 2016 Jan 21.
10
Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment.
Metabolism. 2016 Feb;65(2):124-39. doi: 10.1016/j.metabol.2015.10.007. Epub 2015 Nov 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验